News
This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...
Meril has announced the appointment of Biplab G. as its Business Head - APAC, Arthroplasty Portfolio, based in Mumbai, with a ...
Meril Life Sciences today announced one-year results from a pivotal trial evaluating its balloon-expandable Myval THV system.
Meril Life Sciences announced one-year results from its pivotal LANDMARK trial, presented during the prestigious ...
Looking toward approval in the US, larger studies with careful hemodynamic data will be needed, says Martin Leon.
The Myval THV series demonstrated non-inferiority to contemporary THVs in terms of 1-year clinical efficacy composite endpoint (Myval THV Series: 13% vs. Contemporary THV: 13.1%, difference: -0.1% ...
First-of-its-kind head-to-head TAVI trial reinforces the performance and safety of the Next Gen Myval THV series VAPI, India, May 22, 2025 /PRNewswire/ -- Meril Life Sciences announced one-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results